Global Times: Friendship Lives: Kuliang bond forges ‘hometown affection’ across the Pacific

Global Times: Friendship Lives: Kuliang bond forges 'hometown affection' across the Pacific China-US youth and historic Kuliang ties continue to inspire cultural exchange, friendship, and hopes for future cooperation. GlobeNewswire November 28, 2025 Beijing, China, Nov. 27, 2025 (GLOBE NEWSWIRE) — On the banks of the Minjiang River and atop Kuliang hills, a heartwarming century-old […]

Xi extends congratulations on Intl Day of Solidarity with Palestinian People

Beijing, China, Nov. 27, 2025 (GLOBE NEWSWIRE) — Chinese President Xi Jinping has sent congratulations to a UN meeting held on Tuesday to commemorate the International Day of Solidarity with the Palestinian People, the Xinhua News Agency reported on Wednesday. In his message, Xi said that the Palestinian issue lies at the heart of the

Xi extends congratulations on Intl Day of Solidarity with Palestinian People

Xi extends congratulations on Intl Day of Solidarity with Palestinian People Global Times: Xi urges ceasefire, supports Palestinian rights; calls for two-state solution and urgent Gaza relief. GlobeNewswire November 28, 2025 Beijing, China, Nov. 27, 2025 (GLOBE NEWSWIRE) — Chinese President Xi Jinping has sent congratulations to a UN meeting held on Tuesday to commemorate

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger – GIFI, MOVE, NUVSF and ORBI

We wish you a Happy Thanksgiving and Class Action Attorney Juan Monteverdewith Monteverde & Associates PC(the “M&A Class Action Firm”), who has recovered millions of dollars for shareholders and is recognized as a Top 50Firm in the 2024 ISS Securities Class Action Services Report, is investigating: — Gulf Island Fabrication, Inc. (NASDAQ: GIFI) related to

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger – RMBI, THS, LEGT and NDTAF

We wish you a Happy Thanksgiving and Class Action Attorney Juan Monteverdewith Monteverde & Associates PC(the “M&A Class Action Firm”), who has recovered millions of dollars for shareholders and is recognized as a Top 50Firm in the 2024 ISS Securities Class Action Services Report, is investigating: — Richmond MutualBancorporation, Inc. (NASDAQ: RMBI)related to its merger

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger – RPTX, AXTA, WTG and SEMR

We wish you a Happy Thanksgiving and Class Action AttorneyJuan Monteverdewith Monteverde & Associates PC(the “M&A Class Action Firm”), who has recovered millions of dollars for shareholders and is recognized as a Top 50Firm in the 2024 ISS Securities Class Action Services Report, is investigating: https://mma.prnewswire.com/media/443626/Monteverde_Associates_PC_Logo.jpg — Repare Therapeutics Inc. (NASDAQ: RPTX) related to its

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN

We wish you a Happy Thanksgiving and Class Action Attorney Juan Monteverdewith Monteverde & Associates PC(the “M&A Class Action Firm”), who has recovered millions of dollars for shareholders and is recognized as a Top 50Firm in the 2024 ISS Securities Class Action Services Report, is investigating: — Exact Sciences Corporation (NASDAQ: EXAS) related to its

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LRN

New York, New York–(Newsfile Corp. – November 27, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline. SO WHAT: If

The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma

On November 25, 2025, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech”, HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or metastatic urothelial carcinoma (UC) patients has been published in the journal of Annals of Oncology (Impact Factor: 65.4). This study provides the first evidence of sac-TMT's potential significant clinical benefit

Xinhua Silk Road: Chinese tin industry giant to expand global presence with innovative endeavors

Southwest China-situated refined tin producerYunnan Tin Group (Holding) Co., Ltd. is revving up its paces to delve deeper into global tin market with innovation-led growth now. https://mma.prnewswire.com/media/2833987/19380375e154471ca1085b40d4308434.jpg After the century-old efforts, the Chinese tin industry giant has built up a complete industrial chain that covers mining, processing, smelting, tin materials, tin chemicals and related recycling,

Scroll to Top